BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37718809)

  • 1. Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease.
    Sakurai K; Kaneda D; Morimoto S; Uchida Y; Inui S; Kimura Y; Kato T; Ito K; Hashizume Y
    J Alzheimers Dis; 2023; 95(4):1657-1665. PubMed ID: 37718809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.
    Desmarais P; Gao AF; Lanctôt K; Rogaeva E; Ramirez J; Herrmann N; Stuss DT; Black SE; Keith J; Masellis M
    Alzheimers Res Ther; 2021 Jul; 13(1):129. PubMed ID: 34256835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
    Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer's disease pathology.
    Tando S; Kasai T; Mizuta I; Takahashi H; Yaoi T; Saito K; Hojo T; Mizuno T; Hasegawa M; Itoh K
    Neuropathology; 2021 Jun; 41(3):214-225. PubMed ID: 33537992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.
    Mesulam MM; Weintraub S; Rogalski EJ; Wieneke C; Geula C; Bigio EH
    Brain; 2014 Apr; 137(Pt 4):1176-92. PubMed ID: 24574501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural correlates of the DemTect in Alzheimer's disease and frontotemporal lobar degeneration - A combined MRI & FDG-PET study.
    Woost TB; Dukart J; Frisch S; Barthel H; Sabri O; Mueller K; Schroeter ML
    Neuroimage Clin; 2013; 2():746-58. PubMed ID: 24179826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
    Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
    Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.
    Buciuc M; Martin PR; Tosakulwong N; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
    Neuroimage Clin; 2022; 34():102954. PubMed ID: 35168140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration.
    Barnes J; Whitwell JL; Frost C; Josephs KA; Rossor M; Fox NC
    Arch Neurol; 2006 Oct; 63(10):1434-9. PubMed ID: 17030660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.
    van de Pol LA; Hensel A; van der Flier WM; Visser PJ; Pijnenburg YA; Barkhof F; Gertz HJ; Scheltens P
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):439-42. PubMed ID: 16306153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.
    Rohrer JD; Lashley T; Schott JM; Warren JE; Mead S; Isaacs AM; Beck J; Hardy J; de Silva R; Warrington E; Troakes C; Al-Sarraj S; King A; Borroni B; Clarkson MJ; Ourselin S; Holton JL; Fox NC; Revesz T; Rossor MN; Warren JD
    Brain; 2011 Sep; 134(Pt 9):2565-81. PubMed ID: 21908872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome.
    VandeVrede L; La Joie R; Thijssen EH; Asken BM; Vento SA; Tsuei T; Baker SL; Cobigo Y; Fonseca C; Heuer HW; Kramer JH; Ljubenkov PA; Rabinovici GD; Rojas JC; Rosen HJ; Staffaroni AM; Boeve BF; Dickerson BC; Grossman M; Huey ED; Irwin DJ; Litvan I; Pantelyat AY; Tartaglia MC; Dage JL; Boxer AL
    JAMA Neurol; 2023 May; 80(5):495-505. PubMed ID: 37010841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes.
    Valotassiou V; Papatriantafyllou J; Sifakis N; Tzavara C; Tsougos I; Kapsalaki E; Hadjigeorgiou G; Georgoulias P
    Nucl Med Commun; 2012 Dec; 33(12):1267-76. PubMed ID: 23018627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration.
    Ortner M; Goldhardt O; Diehl-Schmid J; Yakushev I; Lanz K; Hedderich DM; Manuilova E; Simon M; Weinberger JP; Grimmer T
    J Prev Alzheimers Dis; 2022; 9(3):491-498. PubMed ID: 35841250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
    Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP.
    Olm CA; Burke SE; Peterson C; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M; Gee JC
    Neuroimage Clin; 2023; 37():103285. PubMed ID: 36508888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer's disease: evidence from the Frontal Behavioral Inventory.
    Konstantinopoulou E; Aretouli E; Ioannidis P; Karacostas D; Kosmidis MH
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):939-46. PubMed ID: 23135894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.